Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
||||
| Revenue: | |||||||
| Revenue from contract with customer | $ 0 | $ 6,519 | $ 0 | $ 6,519 | |||
| Grant and other revenue | 0 | 51,007 | 0 | 51,007 | |||
| Total Revenue | 0 | 57,526 | 0 | 57,526 | |||
| Cost of revenue | 0 | 473 | 0 | 473 | |||
| Gross profit | 0 | 57,053 | 0 | 57,053 | |||
| Research and development | 1,106,265 | 1,723,988 | 2,373,718 | 2,893,242 | |||
| Selling, general and administrative | 1,321,433 | 1,255,666 | 2,476,349 | 3,065,695 | |||
| Total operating expenses | 2,427,698 | 2,979,654 | 4,850,067 | 5,958,937 | |||
| Loss from operations | (2,427,698) | (2,922,601) | (4,850,067) | (5,901,884) | [1] | ||
| Other income (expense): | |||||||
| Interest income (expense), net | 614,380 | (83,584) | 351,185 | (87,246) | |||
| Gain on amendment of contracts | 0 | 0 | 1,226,432 | 0 | |||
| Gain on sale of non-financial asset – NAV4694 | 750,000 | 750,000 | |||||
| Loss on extinguishment of debt | (185,056) | 0 | (185,056) | 0 | |||
| Other, net | (144,810) | 6,726 | (162,008) | 2,427 | |||
| Total other income (expense), net | 1,034,514 | (76,858) | 1,980,553 | (84,819) | |||
| Loss from continuing operations | (1,393,184) | (2,999,459) | (2,869,514) | (5,986,703) | |||
| Discontinued operations, net of tax effect: | |||||||
| Gain on discontinued operations – Lymphoseek® | 7,425,000 | 0 | 7,425,000 | 0 | |||
| Net income (loss) | 6,031,816 | (2,999,459) | 4,555,486 | (5,986,703) | |||
| Net income attributable to noncontrolling interest | 0 | 1 | 1 | 3 | |||
| Preferred stock dividends | (68,937) | 0 | (68,937) | 0 | |||
| Deemed dividend on preferred stock exchanged | (138,045) | 0 | (138,045) | 0 | |||
| Net income (loss) attributable to common stockholders | $ 5,824,834 | $ (2,999,458) | $ 4,348,505 | $ (5,986,700) | |||
| (Loss) income per common share (basic and diluted) | |||||||
| Continuing operations (in dollars per share) | $ (0.03) | $ (0.10) | $ (0.08) | $ (0.20) | |||
| Discontinued operations (in dollars per share) | 0.15 | 0 | 0.19 | 0 | |||
| Attributable to common stockholders (in dollars per share) | $ 0.12 | $ (0.10) | $ 0.11 | $ (0.20) | |||
| Weighted average shares outstanding (in shares) | 48,242,642 | 30,268,858 | 40,491,390 | 30,238,471 | |||
| |||||||
| X | ||||||||||
- Definition Gain (loss) related to the amendment of a contract between the parties. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale of nonfinancial asset. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of grant and other revenue recorded during the period. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of nonoperating income (expense) recorded during , including equity method investments. No definition available.
|
| X | ||||||||||
- Definition The amount of deemed dividend on preferred stock. No definition available.
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|